Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Ovid Therapeutics (NASDAQ:OVID) through any online brokerage.
Other companies in Ovid Therapeutics’s space includes: Outlook Therapeutics Inc (NASDAQ:OTLK), Anixa Biosciences Inc (NASDAQ:ANIX), Fortress Biotech Inc (NASDAQ:FBIO), Connect Biopharma Holdings Ltd (NASDAQ:CNTB) and Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL).
Ovid Therapeutics has a consensus price target of $3.82.
The stock price for Ovid Therapeutics (NASDAQ: OVID) is $1.57 last updated December 16, 2025 at 7:53 PM EST.
There are no upcoming dividends for Ovid Therapeutics.
Ovid Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Ovid Therapeutics.
Ovid Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.